scanance.
Sign inGet Premium
CL

Calumet, Inc.

CLMTBasic MaterialsNASDAQ

Specialty Chemicals · Last scanned May 28, 2026

PriceMA150MA200
Loading chart…
End-of-day data · ScananceOpen live chart on TradingView ↗
Indicator snapshot
MA150+33.18%
$25.59

Price above medium-term moving average.

MA200+45.14%
$23.48

Above long-term trend line.

RSI-14neutral
47.4

Balanced. Not overbought, not oversold.

MACDpositive
+0.1409

Histogram positive — upward momentum.

Financials · Annual
Revenue
$4.14B
-1.2% YoY
Net Income
-$33.8M
+84.8% YoY
EBITDA
$238.2M
+44.8% YoY
Free Cash Flow
$155.6M

Scan Results

Daily timeframe

1 of 4 indicators bullish as of May 27

DateIndicatorDetails
Loading...
About Calumet, Inc.

Calumet, Inc. manufactures, formulates, and markets a slate of specialty branded products and renewable fuels in North America and internationally. The $2.97B market capitalization puts CLMT squarely in mid-cap range for its industry. It operates through Specialty Products and Solutions; Performance Brands; and Montana/Renewables segments.

Key stats
Market Cap$2.97B
Fwd P/E100.24
EPS$-2.16
Beta0.72
52W Change+136.7%
Analysis

Calumet, Inc. carries $2.50B in total debt against $138.6M in cash reserves — debt is roughly 18.0x the cash position. Managing this leverage effectively will be important for long-term financial stability. Annual free cash flow of $155.6M supports ongoing capital allocation decisions and provides a cushion against unexpected expenses or downturns. Revenue has pulled back from $4.69B (2022) to $4.14B (2025), a 12% decline worth watching.

Calumet, Inc. carries a heavier debt load relative to its cash position, which introduces financial risk that investors should weigh. No single metric tells the full story. Reviewing CLMT's risk profile alongside its fundamentals and technical indicators provides a more complete picture.

Links
Not financial advice. Scanance is an educational tool. Past performance does not guarantee future results.PrivacyTerms